Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
545,5 INR | +2,86 % | +2,05 % | +65,10 % |
09.04. | Shilpa Medicare erhält grünes Licht für QIP | MT |
28.03. | Shilpa Medicare's Life Science Arm ernennt CEO | MT |
Kurzporträt
Mitarbeiterzahl: 1 179
Umsatz nach Geschäftsbereich
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Pharmaceutical Product and Services
99,2
%
| 11 354 | 99,1 % | 10 415 | 99,2 % | -8,27 % |
Others
0,6
%
| 55 | 0,5 % | 67 | 0,6 % | +21,79 % |
Power
0,2
%
| 46 | 0,4 % | 19 | 0,2 % | -58,53 % |
Umsatz je Region
INR in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
India
48,6
%
| 4 880 | 42,6 % | 5 106 | 48,6 % | +4,62 % |
Europe
20,3
%
| 3 252 | 28,4 % | 2 131 | 20,3 % | -34,46 % |
United States
15,6
%
| 1 910 | 16,7 % | 1 639 | 15,6 % | -14,16 % |
Rest of World
15,5
%
| 1 414 | 12,3 % | 1 625 | 15,5 % | +14,94 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 63 | 20.11.87 | |
Alpesh Dalal
DFI | Director of Finance/CFO | - | 31.05.21 |
Chief Tech/Sci/R&D Officer | - | - | |
Compliance Officer | - | 16.03.22 | |
Chief Operating Officer | 58 | 01.06.91 | |
Ritu Tiwary
CMP | Compliance Officer | 47 | 23.05.22 |
R. K. Somani
PRN | Corporate Officer/Principal | - | - |
Awez Pathan
PRN | Corporate Officer/Principal | 55 | - |
Corporate Officer/Principal | 59 | 03.01.08 | |
Corporate Officer/Principal | 60 | 01.01.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 63 | 20.11.87 | |
Director/Board Member | 58 | 02.09.21 | |
Arvind Vasudeva
BRD | Director/Board Member | 63 | 02.09.21 |
Director/Board Member | 76 | 01.07.22 | |
Chairman | 67 | 23.03.88 | |
Chief Operating Officer | 58 | 01.06.91 | |
Director/Board Member | 55 | 11.08.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 97 790 908 | 38 408 541 ( 39,28 %) | 0 | 39,28 % |
Unternehmenskontakt
Shilpa Medicare Ltd.
Shilpa House Hyderabad Road
584135, Raichur
+91 85 3223 8704
http://www.vbshilpa.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
FTF Pharma Pvt Ltd.
FTF Pharma Pvt Ltd. Pharmaceuticals: MajorHealth Technology FTF Pharma Pvt Ltd. engages in the provision of pharmaceutical services. It offers identification of products, regulatory strategy, non-infringing and IP strategy, and bioequivalence and clinical trials. The company was founded by Jayanta Kumar Mandal on June 20, 2012 and is headquartered in Ahmedabad, India. |
Pharmaceuticals: Major
|
Shilpa Biocare Pvt Ltd.
| |
Shilpa Pharma Lifesciences Ltd.
Shilpa Pharma Lifesciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Shilpa Medicare Ltd., Shilpa Pharma Lifesciences Ltd. is an Indian company that manufactures pharmaceutical products. The private company is based in Raichur, India. The company was founded in 2020. Santosh Kumar Mahil has been the CEO of the company since 2024. |
Pharmaceuticals: Major
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Quartalsumsätze - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
+65,10 % | 568 Mio. | |
+25,83 % | 661 Mrd. | |
+27,00 % | 566 Mrd. | |
-6,76 % | 352 Mrd. | |
+20,34 % | 332 Mrd. | |
+3,00 % | 283 Mrd. | |
+13,09 % | 231 Mrd. | |
+5,46 % | 200 Mrd. | |
-9,61 % | 195 Mrd. | |
-6,26 % | 145 Mrd. |
- Börse
- Aktien
- A2AFAH Aktie
- Unternehmen Shilpa Medicare Limited